Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

BACKGROUND & AIMS: Therapeutic drug monitoring (TDM) is widely available for biologic therapies in patients with inflammatory bowel disease (IBD). We reviewed current data and provided expert opinion regarding the clinical utility of TDM for biologic therapies in IBD. METHODS: We used a modified...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Gastroenterol Hepatol
Hoofdauteurs: Papamichael, Konstantinos, Cheifetz, Adam S., Melmed, Gil Y., Irving, Peter M., Casteele, Niels Vande, Kozuch, Patricia L., Raffals, Laura E., Baidoo, Leonard, Bressler, Brian, Devlin, Shane M., Jones, Jennifer, Kaplan, Gilaad G., Sparrow, Miles P., Velayos, Fernando S., Ullman, Thomas, Siegel, Corey A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6661210/
https://ncbi.nlm.nih.gov/pubmed/30928454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.03.037
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items